Is AC Immune (ACIU) Stock Outpacing Its Medical Peers This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has AC Immune (ACIU) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
AC Immune is one of 1091 individual stocks in the Medical sector. Collectively, these companies sit at #5 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. AC Immune is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for ACIU's full-year earnings has moved 1.4% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the most recent data, ACIU has returned 29.9% so far this year. Meanwhile, the Medical sector has returned an average of -9.8% on a year-to-date basis. This shows that AC Immune is outperforming its peers so far this year.
Another stock in the Medical sector, Brainsway Ltd. Sponsored ADR (BWAY), has outperformed the sector so far this year. The stock's year-to-date return is 31.6%.
Over the past three months, Brainsway Ltd. Sponsored ADR's consensus EPS estimate for the current year has increased 17.4%. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, AC Immune belongs to the Medical - Biomedical and Genetics industry, which includes 529 individual stocks and currently sits at #66 in the Zacks Industry Rank. This group has lost an average of 21.5% so far this year, so ACIU is performing better in this area.
On the other hand, Brainsway Ltd. Sponsored ADR belongs to the Medical - Products industry. This 94-stock industry is currently ranked #147. The industry has moved -11.6% year to date.
Going forward, investors interested in Medical stocks should continue to pay close attention to AC Immune and Brainsway Ltd. Sponsored ADR as they could maintain their solid performance.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AC Immune (ACIU) : Free Stock Analysis Report
Brainsway Ltd. Sponsored ADR (BWAY) : Free Stock Analysis Report
